Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Nuvalent Initiates the Phase 2 Portion of ARROS-1 Clinical Trial for Patients with ROS1-Positive NSCLC and other Solid Tumors
Wednesday, September 06, 2023Nuvalent Inc Nasdaq NUVL a clinicalstage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer today announced the initiation of the Phase portion of ARROS
Medivir reports promising interim data, including a first complete response in phase 1b/2a HCC study with fostrox in combination with Lenvima
Monday, September 04, 2023Medivir AB Nasdaq Stockholm MVIR a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today promising interim safety and efficacy data from its ongoing phase ba study of firstin...
Genentech’s Alecensa Delivers Unprecedented Phase III Results for People With ALK-Positive Early-Stage Lung Cancer
Saturday, September 02, 2023Genentech a member of the Roche Group SIX RO ROG OTCQX RHHBY announced today that the Phase III ALINA study evaluating Alecensa alectinib compared with platinumbased chemotherapy met its primary endpoint of diseasefree survival DFS at a prespecified...
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
Friday, September 01, 2023Twist Bioscience Corporation NASDAQ TWST a company enabling customers to succeed through its offering of highquality synthetic DNA using its silicon platform today announced a drug discovery agreement with Ono Pharmaceutical Co Ltd
Otsuka Pharmaceutical to Acquire Mindset Pharma
Friday, September 01, 2023Mindset Pharma Inc CSE MSET FSE DF OTCQB MSSTF Mindset a drug discovery company developing novel optimized nextgeneration psychedelic and nonpsychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023
Thursday, August 31, 2023Denali Therapeutics Inc NASDAQ DNLI a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the bloodbrain barrier for the treatment of neurodegenerative diseases and lysosomal storage diseases today announc...
Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)
Thursday, August 31, 2023Cadrenal Therapeutics Inc Nasdaq CVKD a biopharmaceutical company developing tecarfarin a latestage novel oral and reversible anticoagulant blood thinner to prevent heart attacks strokes and deaths due to blood clots in patients with certain rare med...
Nufactor® Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Specialty Pharmacy to Provide YCANTH™, the First FDA Approved Treatment for Molluscum Contagiosum
Wednesday, August 30, 2023Nufactor Inc a specialty pharmacy and subsidiary of FFF Enterprises Inc announced that it has partnered with Verrica Pharmaceuticals to be the exclusive specialty pharmacy to dispense YCANTH the first FDA approved treatment of molluscum contagiosum i...
BioVaxys and The Ohio State University Extend Research Collaboration
Wednesday, August 30, 2023BioVaxys Technology Corp CSE BIOV OTCQB BVAXF LB FRA BioVaxys or the Company is pleased to announce that it has further extended its research collaboration with The Ohio State University The Ohio State for SARSCoV SARSCoV and pansarbecovirus vaccine...
XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
Wednesday, August 30, 2023XORTX Therapeutics Inc XORTX or the Company NASDAQ XRTX TSXV XRTX Frankfurt ANU a latestage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease announces that it has submitted an Orphan Dru...
